Concepedia

Publication | Open Access

Assessment of a Genomic Assay in Patients With <i>ERBB2</i>-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab

DOIFull Paper Access

28

Citations

10

References

2023

Year

Coralia Bueno, Isabel Echavarría, Sara López‐Tarruella, Marta Roche-Molina, Marı́a del Monte-Millán, Tatiana Massarrah, Yolanda Jerez, Francisco Ayala, José Á. García-Sáenz, Fernando Moreno,
JAMA Oncology

Abstract

This diagnostic/prognostic study demonstrated that the genomic assay predicted pCR following neoadjuvant trastuzumab-based chemotherapy with or without pertuzumab. This assay could guide therapeutic decisions regarding the use of neoadjuvant pertuzumab.

References

YearCitations

Page 1